These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis]. Recks MS, Bader J, Kaiser CC, Schroeter M, Fink GR, Addicks K, Kuerten S. Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707 [Abstract] [Full Text] [Related]
25. The molecular basis of neurodegeneration in multiple sclerosis. Lassmann H, van Horssen J. FEBS Lett; 2011 Dec 01; 585(23):3715-23. PubMed ID: 21854776 [Abstract] [Full Text] [Related]
26. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. Lassmann H. J Neurol Sci; 2003 Feb 15; 206(2):187-91. PubMed ID: 12559509 [Abstract] [Full Text] [Related]
27. [Clinical and pathological topics of multiple sclerosis]. Lassmann H. Rinsho Shinkeigaku; 2009 Nov 15; 49(11):715-8. PubMed ID: 20030193 [Abstract] [Full Text] [Related]
28. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Wang Y, Sun P, Wang Q, Trinkaus K, Schmidt RE, Naismith RT, Cross AH, Song SK. Brain; 2015 May 15; 138(Pt 5):1223-38. PubMed ID: 25724201 [Abstract] [Full Text] [Related]
29. The immunopathology of multiple sclerosis: an overview. Lassmann H, Brück W, Lucchinetti CF. Brain Pathol; 2007 Apr 15; 17(2):210-8. PubMed ID: 17388952 [Abstract] [Full Text] [Related]
30. Axonal damage in multiple sclerosis: a complex issue in a complex disease. Grigoriadis N, Ben-Hur T, Karussis D, Milonas I. Clin Neurol Neurosurg; 2004 Jun 15; 106(3):211-7. PubMed ID: 15177770 [Abstract] [Full Text] [Related]
31. [Multiple sclerosis - a mitochondria-mediated disease?]. Varhaug KN, Vedeler CA, Tzoulis C, Bindoff LA. Tidsskr Nor Laegeforen; 2017 Feb 15; 137(4):284-287. PubMed ID: 28225235 [Abstract] [Full Text] [Related]
32. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis. Meinl E, Krumbholz M, Derfuss T, Junker A, Hohlfeld R. J Neurol Sci; 2008 Nov 15; 274(1-2):42-4. PubMed ID: 18715571 [Abstract] [Full Text] [Related]
33. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis. Magliozzi R, Fadda G, Brown RA, Bar-Or A, Howell OW, Hametner S, Marastoni D, Poli A, Nicholas R, Calabrese M, Monaco S, Reynolds R. Ann Neurol; 2022 Oct 15; 92(4):670-685. PubMed ID: 35748636 [Abstract] [Full Text] [Related]
34. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. Kooi EJ, Geurts JJ, van Horssen J, Bø L, van der Valk P. J Neuropathol Exp Neurol; 2009 Sep 15; 68(9):1021-8. PubMed ID: 19680141 [Abstract] [Full Text] [Related]
35. Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis. Tsouki F, Williams A. Stem Cells; 2021 Aug 15; 39(8):993-1007. PubMed ID: 33754376 [Abstract] [Full Text] [Related]
36. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Owens T. Curr Opin Neurol; 2003 Jun 15; 16(3):259-65. PubMed ID: 12858060 [Abstract] [Full Text] [Related]
37. Influence of neurosteroids on the pathogenesis of multiple sclerosis. Leitner H. Med Hypotheses; 2010 Aug 15; 75(2):229-34. PubMed ID: 20227191 [Abstract] [Full Text] [Related]
38. Brain macrophages acquire distinct transcriptomes in multiple sclerosis lesions and normal appearing white matter. Miedema A, Gerrits E, Brouwer N, Jiang Q, Kracht L, Meijer M, Nutma E, Peferoen-Baert R, Pijnacker ATE, Wesseling EM, Wijering MHC, Gabius HJ, Amor S, Eggen BJL, Kooistra SM. Acta Neuropathol Commun; 2022 Jan 28; 10(1):8. PubMed ID: 35090578 [Abstract] [Full Text] [Related]
39. Meningeal and cortical grey matter pathology in multiple sclerosis. Popescu BF, Lucchinetti CF. BMC Neurol; 2012 Mar 07; 12():11. PubMed ID: 22397318 [Abstract] [Full Text] [Related]